James Cassidy
Chief Tech/Sci/R&D Officer at SPRINGWORKS THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/03/2024
Profile
James Cassidy is currently the Chief Medical Officer at Springworks Therapeutics, Inc. He previously held positions as the Global Head-Translational Research for Oncology at Hoffmann-La Roche, Inc., Professor-Oncology at the University of Glasgow from 2002 to 2011, Vice President-Translational Development at Celgene LLC from 2016 to 2020, Vice President-Oncology at Bristol Myers Squibb Co. from 2013 to 2016, and VP-Oncology Strategic Program Direction at Regeneron Pharmaceuticals, Inc. from 2020 to 2021.
He obtained his doctorate degree from the University of Glasgow in 1981.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/03/2024 | 23,749 ( 0.03% ) | 1 M $ | 30/03/2024 |
James Cassidy active positions
| Companies | Position | Start |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/07/2021 |
Former positions of James Cassidy
| Companies | Position | End |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/07/2021 |
| Celgene LLC | Corporate Officer/Principal | 31/12/2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 30/09/2016 |
| University of Glasgow | Corporate Officer/Principal | 31/12/2010 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Training of James Cassidy
| University of Glasgow | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Celgene LLC |
- Stock Market
- Insiders
- James Cassidy
